The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for reproxalap for the treatment of the signs and symptoms of dry eye disease. Reproxalap is a ...

With an invitation from the Bangladesh Ministry of health and Family Welfare and support from Alcon Cares, the Alcon ...

People only know they have ocular hypertension at an eye exam. It doesn’t cause symptoms. Find out how to lower high eye ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...

Imagine a day when blurry vision becomes a barrier to your daily activities, and a world where glasses seem like the only ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

Surya Eye Hospital unveils Western India's first Oculus Myopia Master for early detection, hosts free myopia screening camp from Nov 14-20: Our Bureau, Mumbai Friday, November 15, ...

Presbyopia is an age-related refractive condition marked by a gradual decline in near vision, typically emerging between ages ...

Diabetic retinopathy is a leading cause of vision loss among adults and often goes unnoticed until it reaches advanced stages ...

Optometry Unit, of Yenepoya School of Allied health sciences in collaboration with NSS Unit 4 organized an eye screening camp ...

In conjunction with the screening camp, Surya Eye Hospital will host a Media Round Table on November 12 ... Surya Eye Hospital & Dr Jay Goyal, LASIK and Refractive Cataract Specialist at Surya Eye ...

The tech features a 2mm incision that allows for rapid correction of refractive errors with reduced risks and faster recovery ...